Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias

Author:Peppel, Levi   Lai, Ruo-Yah   Opal, Puneet   Schmahmann, Jeremy   Gomez, Christopher   Paulson, Henry   Zesiewicz, Theresa   Perlman, Susan   Wilmot, George   Ying, Sarah   Onyike, Chiadi   Bushara, K   Geschwind, Michael   Figueroa, Karla   Pulst, Stefan   Subramony, S   Duquette, Antoine   Ashizawa, Tetsuo   Hamedani, Ali   Davis, Marie   Srinivasan, Sharan   Burns, Matthew   Moore, Lauren   Shakkottai, Vikram   Rosenthal, Liana   Kuo, Sheng-Han   Lin, Chi-Ying   

Session Name:S2: Movement Disorders: Epidemiology and Clinical Aspects  

Topic:Movement Disorders  

Program Number:S2.009  

Author Institution:Baylor College of Medicine, Houston, TX  Columbia University Medical Center, New York, NY  Northwestern University Med Sch, Chicago, IL  Massachusettes General Hospital, Boston, MA  University of Chicago, Chicago, IL  University of Michigan, Ann Arbor, MI  University of South Florida, Tampa, FL  UCLA, Los Angeles, CA  Emory University Dept of Neurology, Lilburn, GA  MEEI, Cambridge, MA  Johns Hopkins University SOM, Baltimore, MD  University of Minnesota, Eden Prairie, MN  UCSF, San Francisco, CA  University of Utah, Salt Lake City, UT  University of Florida, Gainesville, FL  CHUM, Montreal, QC, Canada  Methodist Hospital Research Institute, Houston, TX  Hospital of the University of Pennsylvania, Philadelphia, PA  VA Puget Sound, Seattle, WA  National Ataxia Foundation, Chicago, IL  University of Texas Southwestern Medical Center, Dallas, TX  Johns Hopkins School of Medicine, Lutherville, MD  Columbia University, New York, NY  Baylor College of Medicine, Houston, NY  

Prevalence of and Annual Conversion Rates to Mild Cognitive Impairment and Dementia: Prospective, Longitudinal Study of an Essential Tremor Cohort

RAINBOWFISH: Primary Efficacy and Safety Data in Risdiplam-treated Infants with Presymptomatic Spinal Muscular Atrophy (SMA)

A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life, Neurocognition and Seizures

Author:Peters, Katherine   Mellinghoff, Ingo   Van Den Bent, Martin   Blumenthal, Deborah   Touat, Mehdi   Clarke, Jennifer   Mendez, Joe   Yust-Katz, Shlomit   Mason, Warren   Ducray, Francois   Umemura, Yoshie   Nabors, Burt   Holdhoff, Matthias   Hottinger, Andreas   Arakawa, Yoshiki   Sepúlveda, Juan   Wick, Wolfgang   Soffietti, Riccardo   Perry, James   Giglio, Pierre   De La Fuente, Macarena   Maher, Elizabeth   Bottomley, Andrew   Zhao, Dan   Pandya, Shuchi   Hassan, Islam   Steelman, Lori   Wen, Patrick   Cloughesy, Timothy   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Neuro-oncology  

Program Number:PL5.003  

Author Institution:Duke University Medical Center, Durham, NC  Memorial Sloan Kettering Cancer Center, New York, NY  Erasmus Medical Center, Rotterdam, Netherlands  Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel  Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France  University of California San Francisco, San Francisco, CA  Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT  Davidoff Cancer Center at Rabin Medical Center, Petah Tikva, Israel  Toronto General Hospital, Toronto, ON, Canada  Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France  University of Michigan Comprehensive Cancer Center, Ann Arbor, MI  University of Alabama at Birmingham, Birmingham, AL  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD  University Hospital of Lausanne, Lausanne, Switzerland  Kyoto University Graduate School of Medicine, Kyoto, Japan  Hospital Universitario 12 de Octubre, Madrid, Spain  Universitätsklinikum Heidelberg, Heidelberg, Germany  University of Turin, Turin, Italy  Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada  The Ohio State University Wexner Medical Center, Columbus, OH  Sylvester Comprehensive Cancer Center and Department of Neurology, University of Miami, Miami, FL  University of Texas Southwestern Medical Center, Dallas, TX  Bottomley Consultants, Overijse, Belgium  Servier Pharmaceuticals, Boston, MA  Dana-Farber Cancer Institute, Boston, MA  University of California Los Angeles, Los Angeles, CA